Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adipose tissue gene expression and longitudinal clinical phenotypes are early biomarkers of lipid-regulating drug usage

29 Aug 2025

Abstract excerpt

Abstract Cardiovascular disease progression is characterised by the dysregulation of lipid metabolism and pro-atherogenic effects of adipose tissue signalling. Recent findings from the analysis of transcriptomic data in bulk tissue has enabled these insights and revealed important changes in gene expression. However, few studies have explored these molecular mechanisms before the onset of cardiovascular disease....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines, Inflammation, and Metabolic Diseases
Share to Adipose Tissue and Metabolism
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40883367
DOI: 10.1038/s41598-025-13693-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adipose tissue gene expression and longitudinal clinical phenotypes are early biomarkers of lipid-regulating drug usagePMID 40883367Read ↗

CETP alternative splicing variation impacts human traitsSemantic proximity Read ↗

The Multifaceted Role of Epicardial and Pericardial Adipose Tissue in Human Health: a Mendelian randomization studySemantic proximity Read ↗

Genetic regulation of fatty acid content in adipose tissue.Semantic proximity Read ↗

Genetic regulation of fatty acid content in adipose tissueSemantic proximity Read ↗

Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medicationsSemantic proximity Read ↗

Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention responseSemantic proximity Read ↗

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisationSemantic proximity Read ↗

Human subcutaneous adipose tissue variability is driven by VEGFA, ACTA2, adipocyte density, and ancestral history of the patientSemantic proximity Read ↗

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation.Semantic proximity Read ↗

Pharmacogenomic predictors of drug response and choice in dyslipidemia and hypertensionSemantic proximity Read ↗

ACE inhibition and cardiometabolic risk factors, lung <i>ACE2</i> and <i>TMPRSS2</i> gene expression, and plasma ACE2 levels: a Mendelian randomization studySemantic proximity Read ↗

Genetic variation in CADM2 as a link between psychological traits and obesitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.